AQB (AquaBounty Technologies) Short-Term Debt to Capital

AquaBounty Technologies brings together leading genetic engineers and closed-containment system experts to breed GMO salmon. The company is developing land-based aquaculture, ensuring stable product supplies through the integration of biotechnology and modern farms. The price action chart reflects the 0.00 metric, while the business relies on a single product, which, combined with the high cost of plant construction, creates significant financial risks.

For AquaBounty Technologies (AQB), which is protected by unique FDA regulatory barriers, the short-term financial leverage ratio demonstrates the dependence of operational expansion on borrowed capital. This metric is calculated as the ratio of liabilities with a maturity of over one year to equity, measuring the degree of debt load on the balance sheet. An increase in this indicator signals aggressive scaling of GMO salmon production, while its decline confirms financial stability and a low default risk for the asset.